NCT05891158View on ClinicalTrials.gov

A Study About Fazirsiran in People With and Without Liver Problems

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

September 3, 2025

Study Completion Date

September 3, 2025

Conditions
Hepatic Impairment
Interventions
DRUG

Fazirsiran

Fazirsiran SC injection

Trial Locations (4)

2143

CRU Hungary Kft, Kistarcsa

851 05

Summit Clinical Research s.r.o., Bratislava

Unknown

Summit Clinical Research s.r.o., Malacky

940 34

Summit Clinical Research s.r.o., Nové Zámky

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY